相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
Irene L. M. Reijers et al.
NATURE MEDICINE (2022)
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
N. D. Gross et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Outcomes of patients with metastatic cutaneous squamous cell carcinoma to the axilla: a multicentre cohort study
Phillip F. Yang et al.
ANZ JOURNAL OF SURGERY (2021)
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial
Michael R. Migden et al.
LANCET ONCOLOGY (2020)
ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee
O. Michielin et al.
ANNALS OF ONCOLOGY (2020)
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing
Danny Rischin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Number of nodal metastases and prognosis in metastatic cutaneous squamous cell carcinoma of the head and neck
Ashish Sood et al.
ANZ JOURNAL OF SURGERY (2019)
Review of systemic agents in the treatment of advanced cutaneous squamous cell carcinoma
Erik T. Petersen et al.
FUTURE ONCOLOGY (2019)
Squamous Cell Carcinoma with Regional Metastasis to Axilla or Groin Lymph Nodes: a Multicenter Outcome Analysis
George Pang et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England
Zoe C. Venables et al.
JAMA DERMATOLOGY (2019)
Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial
Sandro Virgilio Porceddu et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Cutaneous squamous cell carcinoma Incidence, risk factors, diagnosis, and staging
Syril Keena T. Que et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
M. R. Migden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Alexander M. M. Eggermont et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
Christian U. Blank et al.
NATURE MEDICINE (2018)
Anti-programmed cell death-1 therapy in nonmelanoma skin cancer
J. K. Winkler et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Prospective study of definitive chemoradiation in locally or regionally advanced squamous cell carcinoma of the skin
Michelle K. Nottage et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: Case report and review of the literature
Teresa Deinlein et al.
EUROPEAN JOURNAL OF CANCER (2017)
Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck
Nir Hirshoren et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma
J. Canueto et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Drug therapy of advanced cutaneous squamous cell carcinoma: is there any evidence?
Simone Ribero et al.
CURRENT OPINION IN ONCOLOGY (2017)
Rescue therapy with anti-programmed cell death protein 1 inhibitors of advanced cutaneous squamous cell carcinoma and basosquamous carcinoma: preliminary experience in five cases
L. Borradori et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Efficacy of neoadjuvant cetuximab alone or with platinum salt for the treatment of unresectable advanced nonmetastatic cutaneous squamous cell carcinomas
M. Reigneau et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial
Michael A. Henderson et al.
LANCET ONCOLOGY (2015)
Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 2012
Howard W. Rogers et al.
JAMA DERMATOLOGY (2015)
Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy
Robert M. Samstein et al.
JOURNAL OF SKIN CANCER (2014)
Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies
Louise Lansbury et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
A systematic review of worldwide incidence of nonmelanoma skin cancer
A. Lomas et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors
Nicholas D. L. S. Brougham et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin
Eve Maubec et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes
Michael J. Veness et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2007)
分享论文
